Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas. – UroToday
|
Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
UroToday Immunotherapy offers a new potential treatment paradigm with great promise. Immunotherapy of soft tissue sarcomas dates back to Dr. Coley’s first use of toxins in the late 1800s. A variety of strategies of immunotherapy have been tried in soft tissue … |
Investopedia |
8 Stocks for the Next Gene Revolution
Investopedia The next frontier in biotech is shaping up to be gene-replacement therapy to treat a wide range of serious, sometimes deadly, inherited diseases, Barron’s reports. The U.S. Food and Drug Administration (FDA) is currently reviewing such a treatment for … |
Science Magazine |
Is a new embryo-editing technique better than CRISPR?
Science Magazine A new technique to correct mutations that cause disease has shown promise in a human embryo study. The disease β-thalassemia, a blood disorder, is caused by a mistake in a single DNA base. A study in Protein & Cell describes how researchers used … ‘Chemical surgery’ used to mend harmful mutations in human embryosThe Guardian DNA surgery on embryos removes disease – BBC NewsBBC News New ‘Chemical Surgery’ Technique Repairs Mutations in Human EmbryosGizmodo Phys.Org –HuffPost UK –Telegraph.co.uk –Springer Link all 23 news articles » |
|
Stem cell clinic approved for UC Davis
Sacramento Bee The California stem cell agency Thursday awarded UC Davis $7.9 million to create an “Alpha” stem cell clinic that will serve patients in a 33-county area in Northern California. The award brings to about $140 million the funds that the campus has … Nohla Therapeutics Awarded $6.9 Million Grant from the California Institute of Regenerative Medicine to Further …GlobeNewswire (press release) |